Tevard Biosciences
Julien Oury is a Principal Scientist at Tevard Biosciences since June 2023. Previously, held positions as a Senior Scientist at NYU Langone Health from September 2013 to June 2023, and as a Postdoctoral Researcher at IGBMC from September 2008 to December 2012. Holds a PhD in Biochemistry from the University of Strasbourg, completed in 2012, a Master's degree in Molecular and Cellular Physiopathology, completed in 2008, and a Bachelor's degree in Cell/Cellular and Molecular Biology, completed in 2006.
Tevard Biosciences
Tevard Biosciences is a biotechnology company pioneering tRNA-based gene therapies to cure rare and severe genetic diseases with limited or no approved treatment options.